Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

1,535 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Rational Design of Asymmetric Polymethines to Attain NIR(II) Bioimaging at >1100 nm.
Pan HM, Wu CC, Lin CY, Hsu CS, Tsai YC, Chowdhury P, Wang CH, Chang KH, Yang CH, Liu MH, Chen YC, Su SP, Lee YJ, Chiang HK, Chan YH, Chou PT. Pan HM, et al. Among authors: tsai yc. J Am Chem Soc. 2023 Jan 11;145(1):516-526. doi: 10.1021/jacs.2c10860. Epub 2022 Dec 23. J Am Chem Soc. 2023. PMID: 36562565
FHL2 in arterial medial calcification in chronic kidney disease.
Liao YR, Tsai YC, Hsieh TH, Tsai MT, Lin FY, Lin SJ, Lin CC, Chiang HY, Chu PH, Li SY. Liao YR, et al. Among authors: tsai yc. Nephrol Dial Transplant. 2024 Apr 25:gfae091. doi: 10.1093/ndt/gfae091. Online ahead of print. Nephrol Dial Transplant. 2024. PMID: 38664060
Reversal of C9orf72 mutation-induced transcriptional dysregulation and pathology in cultured human neurons by allele-specific excision.
Sachdev A, Gill K, Sckaff M, Birk AM, Aladesuyi Arogundade O, Brown KA, Chouhan RS, Issagholian-Lewin PO, Patel E, Watry HL, Bernardi MT, Keough KC, Tsai YC, Smith AST, Conklin BR, Clelland CD. Sachdev A, et al. Among authors: tsai yc. Proc Natl Acad Sci U S A. 2024 Apr 23;121(17):e2307814121. doi: 10.1073/pnas.2307814121. Epub 2024 Apr 15. Proc Natl Acad Sci U S A. 2024. PMID: 38621131 Free PMC article.
Clinical outcome of bevacizumab or ramucirumab combined with epidermal growth factor receptor (EGFR) tyrosine kinase inhibitors as the first line therapy in susceptible EGFR-mutated advanced non-small-cell lung.
Kuo CY, Tsai MJ, Hung JY, Lee MH, Wu KL, Tsai YC, Chuang CH, Huang CW, Chen CL, Yang CJ, Chong IW. Kuo CY, et al. Among authors: tsai yc. Kaohsiung J Med Sci. 2024 May;40(5):467-476. doi: 10.1002/kjm2.12822. Epub 2024 Mar 25. Kaohsiung J Med Sci. 2024. PMID: 38523603 Free article.
1,535 results